{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-060305","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-05-13T20:36:26+00:00","discovered_at":"2026-05-13T20:37:00.603992+00:00","generated_at":"2026-05-13T20:39:37.892062+00:00","sec_items":["1.01","1.02","2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"confidence":"high","headline":"Outlook Therapeutics enters new $100M ATM with H.C. Wainwright; cash at $7.7M","bullets":["Entered into $100M at-the-market offering agreement with H.C. Wainwright & Co. as sales agent.","Prior $100M ATM with BTIG terminated effective May 12, 2026.","Preliminary cash and cash equivalents of $7.7M as of March 31, 2026 (unaudited), plus $4.5M from April 2026 direct offering.","H.C. Wainwright will receive a 3% commission on gross proceeds from shares sold under the ATM."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-060305","json":"https://secwatch.observer/filing/0001104659-26-060305.json","markdown":"https://secwatch.observer/filing/0001104659-26-060305.md","text":"https://secwatch.observer/filing/0001104659-26-060305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/0001104659-26-060305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/tm2614480d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T20:39:37.892062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}